{"id":569,"date":"2024-05-24T13:15:30","date_gmt":"2024-05-24T05:15:30","guid":{"rendered":"http:\/\/10.0.20.30:8080\/wordpress4\/?p=569"},"modified":"2024-07-11T17:16:25","modified_gmt":"2024-07-11T09:16:25","slug":"%e5%96%9c%e8%ba%8d%e7%94%9f%e9%86%ab5%e6%9c%88%e6%8f%90%e7%95%b0%e9%ab%94%e7%b4%b0%e8%83%9e%e8%87%ba%e8%85%a6%e6%80%a7%e9%ba%bb%e7%97%ba%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a9%97%e3%80%81%e5%b9%b4%e5%ba%95i","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=569","title":{"rendered":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year"},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg 1024w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9-300x300.jpg 300w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9-150x150.jpg 150w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n<p>VCRO assists clients in submitting applications for phase I\/II clinical trials. With extensive practical experience in the field of cell therapy, VCRO has successfully completed 47 commissioned service cases to date, establishing ourselves as a leading brand in Taiwan&#8217;s cell therapy clinical trial arena.<\/p>\n\n\n\n<p>Choosing VCRO means gaining professional support and excellent service; we are committed to helping every client succeed on their journey in cell therapy.<\/p>\n\n\n\n<p>If you need our services, feel free to contact us anytime via our official Facebook page or Line official account for interaction with our team!<\/p>\n\n\n\n<p>News Link:\u00a0<a href=\"https:\/\/news.gbimonthly.com\/tw\/article\/show.php?num=67817\">https:\/\/news.gbimonthly.com\/tw\/article\/show.php?num=67817<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>VCRO assists clients in submitting applications for phase I\/II clinical trials. With extensive practical experience in the field of cell therapy, VCRO has successfully completed 47 commissioned service cases to date, establishing ourselves as a leading brand in Taiwan&#8217;s cell therapy clinical trial arena. Choosing VCRO means gaining professional support and excellent service; we are [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[15],"class_list":["post-569","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-news","tag-cell-therapy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO<\/title>\r\n<meta name=\"description\" content=\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=569\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=569\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2024-05-24T05:15:30+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-11T09:16:25+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year\",\"datePublished\":\"2024-05-24T05:15:30+00:00\",\"dateModified\":\"2024-07-11T09:16:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569\"},\"wordCount\":129,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\",\"keywords\":[\"Cell therapy\"],\"articleSection\":[\"Industry news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=569\",\"name\":\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\",\"datePublished\":\"2024-05-24T05:15:30+00:00\",\"dateModified\":\"2024-07-11T09:16:25+00:00\",\"description\":\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=569\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=569#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO","description":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=569","og_locale":"en_US","og_type":"article","og_title":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO","og_description":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=569","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2024-05-24T05:15:30+00:00","article_modified_time":"2024-07-11T09:16:25+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg","type":"image\/jpeg"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=569#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=569"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year","datePublished":"2024-05-24T05:15:30+00:00","dateModified":"2024-07-11T09:16:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=569"},"wordCount":129,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=569#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg","keywords":["Cell therapy"],"articleSection":["Industry news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=569","url":"https:\/\/www.vcro.com.tw\/?p=569","name":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=569#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=569#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg","datePublished":"2024-05-24T05:15:30+00:00","dateModified":"2024-07-11T09:16:25+00:00","description":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=569#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=569"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=569#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d3f62f09-ee05-4b05-ac1f-a96dd0da9ba9.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=569#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"In May, Xi Yue Biomedicine announced the clinical trial of allogeneic stem cell therapy for cerebral palsy, with plans for an IPO end this year"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=569"}],"version-history":[{"count":9,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/569\/revisions"}],"predecessor-version":[{"id":1544,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/569\/revisions\/1544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1412"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}